CPAPE | 2025 China Pharmaceutical Industry Technology Conference and the 15th Annual Meeting of China Medical Equipment Engineering Association have come to a successful conclusion
Release time：
2025-03-14
Innovation, collaboration, integration, and win-win outcomes
The 2025 China Pharmaceutical Industry Technology Conference and the 15th Annual Meeting of the China Medical Equipment Engineering Association will be held in Chengdu from March 12th to 14th. The theme of this conference is "Innovation Collaboration, Integration and Win win", focusing on the intelligent, international and coordinated development of the pharmaceutical industry and industrial chain. It explores the application of cutting-edge technologies represented by intelligent manufacturing and new trends in global cooperation and policies and regulations, injecting new momentum into the high-quality development of China's pharmaceutical industry.
MayAir was invited to attend the conference, and the sales and technical team of the Biomedical Division showcased their clean air solutions for the biopharmaceutical industry. Among them, the comprehensive clean room solution that meets GMP workshop purification requirements, diversified biosafety protection products applied in laboratories, and customized protection solutions suitable for complex formulation production have attracted numerous industry experts, enterprise representatives, and partners to stop and exchange ideas.
The pharmaceutical industry has almost extreme standard requirements for air cleanliness in production environments due to its high technological barriers, intensive resource investment, long research and development cycles, and strict risk management. This indicator is not only directly related to the final quality of drugs, but also a core element in ensuring drug safety.
In this context, MayAir has always been committed to innovative research and development as its core strategy, focusing on creating one-stop solutions for pharmaceutical production workshops, laboratory microenvironments, and biosafety protection. Through technological means, it effectively reduces the potential threat of toxic substances to personnel and the environment, and ensures that the entire laboratory process complies with international safety regulations.
MayAir, relying on more than 20 years of professional accumulation, has provided clean environment system solutions for the world's top 500 pharmaceutical companies, WHO certified biological laboratories, and authoritative medical institutions through a full lifecycle traceability management system, specialized production system, and full scenario solutions. It has built a core technology matrix covering the entire process of research and development, production, and quality control. In the future, MayAir will continue to use research and development innovation as the engine, work together with global partners, and jointly build a safe, efficient, and sustainable pharmaceutical industry ecosystem.
